Prosecution Insights
Last updated: May 29, 2026

Examiner: HAQ, SHAFIQUL

Tech Center 1600 • Art Units: 1641 1677 1678

This examiner grants 65% of resolved cases

Performance Statistics

64.8%
Allow Rate
+4.8% vs TC avg
961
Total Applications
+55.5%
Interview Lift
1286
Avg Prosecution Days
Based on 935 resolved cases, 2023–2026

Rejection Statute Breakdown

1.5%
§101 Eligibility
9.9%
§102 Novelty
47.2%
§103 Obviousness
21.8%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18620441 PROCESS FOR PURIFICATION OF PROTEIN Non-Final OA Kashiv BioSciences, LLC
17781202 LUMINESCENT ZWITTERIONIC POLYMERIC NANOPARTICLES Final Rejection CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
17889025 DE-CROSSLINKING COMPOUNDS AND METHODS OF USE FOR SPATIAL ANALYSIS Final Rejection 10x Genomics, Inc.
18130874 SELF-HEALABLE CHEMICAL DETECTING SENSOR EMBEDDING TRANSITION METAL-ADSORBED PAA-PVA-BORAX FIBER-GEL Non-Final OA UIF (University Industry Foundation), Yonsei University
17931016 METHODS FOR ANALYSIS OF TARGET MOLECULES IN BIOLOGICAL FLUIDS Non-Final OA GRAIL, LLC
17788779 Methods for Reducing Nonspecific Interactions on Biological Samples Non-Final OA Ultivue, Inc.
18167781 METHODS FOR MONITORING PATIENT RESPONSE TO TREATMENT OF RETINAL OXIDATIVE DISEASES Non-Final OA BioJiva LLC
17976933 BRIGHT AND RELEASABLE LABELS FOR CELL STAINING BASED ON THE CONJUGATES WITH SEVERAL SITES OF FLUOROPHORE RELEASE Non-Final OA Miltenyi Biotec B.V. & Co. KG
18108828 CHANNELED FIBERS IN SEPARATION OF BIOLOGICALLY ACTIVE NANOPARTICLES Final Rejection CLEMSON UNIVERSITY RESEARCH FOUNDATION
18251279 IMPROVED ASSAYS TO DETECT NUCLEOSOME MODIFICATIONS USING ANTIBODY-TARGETED ENZYME DIGESTION Non-Final OA EPICYPHER, INC.
17199228 SAMPLE DEPLETION AND ENRICHMENT TO IMPROVE THE QUALITY OF DIAGNOSTIC TEST RESULTS Final Rejection VERAVAS, INC.
17998559 DRUG CONJUGATES CONTAINING ALPHA-ENOLASE ANTIBODIES AND USES THEREOF Non-Final OA HUNILIFE BIOTECHNOLOGY, INC.
17923262 CELLULAR MATERIAL DETECTION PROBES Non-Final OA FLUORETIQ LIMITED
17965761 FREEZE-DRIED PREPARATION OF CHEMILUMINESCENT IMMUNE MICROSPHERES, AND PREPARATION METHOD AND APPLICATION THEREOF Non-Final OA Anbio (Xiamen) Biotechnology Co., Ltd
17802852 NANOPARTICLES FOR SENSING USE AND PRODUCTION METHOD FOR SAME Non-Final OA TearExo Inc.
17409066 Predictive Markers Useful in the Treatment of Wet Age-Related Macular Degeneration Final Rejection MAINTECT GMBH
17316665 NANODIAMOND PARTICLES AND RELATED DEVICES AND METHODS Final Rejection Debina Diagnostics, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month